论文期刊

取消

高级检索

检索历史清除

首页> Cancer> Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma.

Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma.

导出原文传递

翻译打印收藏纠错

作者： Mariano,Russo ^[1] ; Jordan M,Newell ^[2] ; Laura,Budurlean ^[3] ; Kenneth R,Houser ^[1] ; Kathryn,Sheldon ^[2] ; Joshua,Kesterson ^[1] ; Rebecca,Phaeton ^[2] ; Carrie,Hossler ^[1] ; Jennifer,Rosenberg ^[2] ; David,DeGraff ^[4] ; Lauren,Shuman ^[4] ; James R,Broach ^[4] ; Joshua I,Warrick ^[5]

作者单位： Department of Biochemistry, Penn State College of Medicine, Penn State Health, Hershey, Pennsylvania. ^[1] Institute for Personalized Medicine, Penn State College of Medicine, Penn State Health, Hershey, Pennsylvania. ^[2] Department of Pathology, Penn State College of Medicine, Penn State Health, Hershey, Pennsylvania. ^[3] Department of Obstetrics and Gynecology, Penn State College of Medicine, Penn State Health, Hershey, Pennsylvania. ^[4] Department of Radiation Oncology, Penn State College of Medicine, Penn State Health, Hershey, Pennsylvania. ^[5]

关键词 endometrial cancer endometrial hyperplasia endometrial intraepithelial neoplasia genetics genomics

主题词成年人(Adult);老年人(Aged);癌, 子宫内膜样(Carcinoma, Endometrioid);I类磷脂酰肌醇3-激酶类(Class I Phosphatidylinositol 3-Kinases);DNA结合蛋白质类(DNA-Binding Proteins);子宫内膜增生(Endometrial Hyperplasia);子宫内膜肿瘤(Endometrial Neoplasms);女(雌)性(Female);高通量核苷酸序列分析(High-Throughput Nucleotide Sequencing);人类(Humans);中年人(Middle Aged);突变(Mutation);PTEN磷酸水解酶(PTEN Phosphohydrolase);受体, 成纤维细胞生长因子, 2型(Receptor, Fibroblast Growth Factor, Type 2);回顾性研究(Retrospective Studies);转录因子(Transcription Factors);青年人(Young Adult)

DOI 10.1002/cncr.32822

PMID 32187665

发布时间 2021-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览24

Cancer

Cancer

2020年126卷12期

2775-2783页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷